帕博西林治疗晚期乳腺癌的研究进展(4)
[15] Gelbert L M，Cai S，Lin X，et al.Preclinical characterization of the CDK4/6 inhibitor LY2835219：in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine[J].Investig New Drugs ......
您现在查看是摘要页，全文长 1895 字符。